Ancient herbal paste put to the test for better sleep
NCT ID NCT07504536
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This phase 2 trial tests whether a traditional Chinese herbal paste called Ning Shen Dan Xiang Gao Fang, made with donkey-hide gelatin, can improve sleep in adults with chronic insomnia. Sixty participants will take the paste or a placebo twice daily for 8 weeks. Researchers will measure sleep quality using questionnaires and sleep diaries.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Ningshen Danxiang Donkey-hide Gelatin Medicated Paste (traditional Chinese herbal paste)
- What this could lead to
- If it works, this could offer a new herbal option for people with chronic insomnia, especially those with a heart-kidney imbalance pattern.
- What could go wrong
- This is a small, early-phase trial with only 60 participants. The placebo effect is strong in insomnia studies, so the results may not be conclusive or widely applicable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Seventh People's Hospital
Shanghai, Pudong New Area, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light therapy during sleep may offer a Drug-Free path to better rest
- Mind over bladder: can sleep training curb nighttime urges?
- Can an ancient herbal formula unlock better sleep and weight loss?
- Could a simple sleep guide ease insomnia in lung disease?
- Digital sleep coaching for seniors: a new hope for insomnia?
- Fixing sleep, fortifying hearts: a new trial tests the link